Ain K B, Refetoff S, Sarne D H, Murata Y
University of Chicago, Department of Medicine, Illinois 60637.
Mol Endocrinol. 1988 Apr;2(4):313-23. doi: 10.1210/mend-2-4-313.
Hyperestrogenemia in humans increases both the concentration of serum T4-binding globulin (TBG) by 2- to 3-fold and the proportion having anodal mobility on isoelectric focusing (IEF). As TBG is synthesized in the liver, we studied the effect of estrogen on TBG synthesis, secretion, and degradation by cultured human hepatocarcinoma cells (Hep G2). beta-Estradiol in concentrations in the range found in pregnancy (10(-7) M) had no effect on the accumulation of immunoreactive TBG in medium over 4 days. The absence of fetal calf serum or phenol red did not alter these findings. The amount of [35S]TBG accumulated 6 h after addition of [35S]methionine was not influenced by exposure to estrogen or to serum obtained from pregnant women. However, 10(-5) M beta-estradiol suppressed TBG more severely than albumin synthesis (34% vs. 9%). The lack of an estrogen effect on TBG synthesis and secretion was supported by experiments showing no effect of estrogen on the disappearance of TBG added to the medium or the accumulation of cytoplasmic TBG mRNA. The same cultures responded to estrogen by a 10-fold increase in nuclear estrogen receptor binding sites and a 2-fold increase in apolipoprotein CII. As TBG in serum, the rate of heat denaturation was not altered in TBG synthesized by Hep G2 cells in the presence of estrogen. In contrast to the effect on TBG in serum, in Hep G2 cells estrogen did not produce an anodal shift on IEF, or increased its proportion not bound to Concanavalin A, nor reduced its clearance rate when injected into rats. However, even untreated Hep G2 cells synthesized TBG with a larger number of anodal IEF bands and proportion of Concanavalin A excluded material than TBG in pregnancy serum. Results support our hypothesis, based on analysis of TBG in pregnancy, that estrogen-induced serum TBG elevation may not be mediated through an increase in synthesis. The failure to observe estrogen induced changes in oligosaccharide structure does not exclude estrogen responsivity of Hep G2 cells. Such effect could be masked by the marked constitutive increase in number of oligosaccharide chain antennae typical in this and other neoplastic tissues.
人类高雌激素血症会使血清甲状腺素结合球蛋白(TBG)的浓度增加2至3倍,并使等电聚焦(IEF)时具有阳极迁移率的比例增加。由于TBG是在肝脏中合成的,我们研究了雌激素对培养的人肝癌细胞(Hep G2)合成、分泌和降解TBG的影响。妊娠时浓度范围内(10⁻⁷ M)的β-雌二醇对4天内培养基中免疫反应性TBG的积累没有影响。不含胎牛血清或酚红并不改变这些结果。添加[³⁵S]甲硫氨酸6小时后积累的[³⁵S]TBG量不受雌激素或孕妇血清暴露的影响。然而,10⁻⁵ M的β-雌二醇对TBG的抑制作用比对白蛋白合成的抑制作用更严重(34%对9%)。雌激素对TBG合成和分泌缺乏影响得到了实验的支持,这些实验表明雌激素对添加到培养基中的TBG的消失或细胞质TBG mRNA的积累没有影响。相同的培养物对雌激素的反应是核雌激素受体结合位点增加10倍,载脂蛋白CII增加2倍。与血清中的TBG一样,在雌激素存在下由Hep G2细胞合成的TBG的热变性速率没有改变。与对血清中TBG的影响相反,在Hep G2细胞中,雌激素不会在IEF上产生阳极迁移,也不会增加其不与伴刀豆球蛋白A结合的比例,也不会在注射到大鼠体内时降低其清除率。然而,即使未经处理的Hep G2细胞合成的TBG在IEF上的阳极条带数量也比妊娠血清中的TBG多,且不与伴刀豆球蛋白A结合的物质比例更高。结果支持了我们基于对妊娠时TBG的分析得出的假设,即雌激素诱导的血清TBG升高可能不是通过合成增加介导的。未能观察到雌激素诱导的寡糖结构变化并不排除Hep G2细胞对雌激素有反应性。这种作用可能被这种及其他肿瘤组织中典型的寡糖链触角数量的显著组成性增加所掩盖。